---
figid: PMC5878997__nihms922040f3
figlink: /pmc/articles/PMC5878997/figure/F3/
number: Figure 3
caption: In the classic nuclear signaling pathway (1) progesterone activates progesterone
  receptor (PR) by binding and inducing conformational changes of the receptor causing
  in turn nuclear translocation, dimerization and binding to progesterone response
  elements (PRE) in the promoters or enhancer regions of PR target genes. Progestin
  treatment rapidly activates extranuclear signaling of a subpopulation of PR localized
  in the membrane or cytoplasm to transiently associate with c-Src through interaction
  with the PR polyproline domain (PPD) leading to activation of mitogen-activated
  protein kinase (MAPK), phosphatidylinositol 3-kinase (PI3K/Akt), or Janus kinase/signal
  transducers and activators of transcription (JAK/STAT) signaling pathways. Activated
  MAPK further regulates PR transcriptional activity through phosphorylation of PR,
  co-activators (1) or other transcription factors (2). Rapid progestin activation
  of MAPK can directly phosphorylate PR or co-activators (1) or promote PR phosphorylations
  through CK2 and CDK2 (see text for details). Alternatively, activation of various
  cytoplasmic signaling pathways may phosphorylate and increase transcriptional activity
  of other transcription factors, independent of PREs (2). Rapid extranuclear activation
  of ER/PR complexes by progestins activates MAPK leading to a formation of phospho-PR/MAPK/Msk1
  (Mitogen and stress-activated protein kinase 1), chromatin remodeling and enhanced
  MMTV and PRE-containing gene transcription (3). PR extranuclear activation of Src/PI3K/Akt
  may stimulate focal adhesion kinase (FAK) or ribosomal S6 kinase 1 (RSK1) triggering
  actin cytoskeleton remodeling and promotion of cell motility (4). Alternatively,
  PR extranuclear signaling may cross-communicate with growth factor signaling such
  as epidermal growth factor (EGF) leading to activation of MAPK and downstream events
  (5). Membrane localized progestin receptor (mPR) unrelated to the classical PR mediates
  progestin extranuclear signaling through GPCR-like membrane proteins via modulation
  of adenylate cyclase (AC), cyclic adenosine monophosphate (cAMP) and protein kinase
  A (PKA). mPR has been reported to activate MAPK and PI3K/Akt signaling pathways.
  More work is needed to define the physiological significance of extranuclear mPR
  activation of these several cytoplasmic signaling pathways in BC cells.
pmcid: PMC5878997
papertitle: Extranuclear Signaling by Sex Steroid Receptors and Clinical Implications
  in Breast Cancer.
reftext: Viroj Boonyaratanakornkit, et al. Mol Cell Endocrinol. ;466:51-72.
pmc_ranked_result_index: '43529'
pathway_score: 0.9580148
filename: nihms922040f3.jpg
figtitle: Extranuclear Signaling by Sex Steroid Receptors and Clinical Implications
  in Breast Cancer
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5878997__nihms922040f3.html
  '@type': Dataset
  description: In the classic nuclear signaling pathway (1) progesterone activates
    progesterone receptor (PR) by binding and inducing conformational changes of the
    receptor causing in turn nuclear translocation, dimerization and binding to progesterone
    response elements (PRE) in the promoters or enhancer regions of PR target genes.
    Progestin treatment rapidly activates extranuclear signaling of a subpopulation
    of PR localized in the membrane or cytoplasm to transiently associate with c-Src
    through interaction with the PR polyproline domain (PPD) leading to activation
    of mitogen-activated protein kinase (MAPK), phosphatidylinositol 3-kinase (PI3K/Akt),
    or Janus kinase/signal transducers and activators of transcription (JAK/STAT)
    signaling pathways. Activated MAPK further regulates PR transcriptional activity
    through phosphorylation of PR, co-activators (1) or other transcription factors
    (2). Rapid progestin activation of MAPK can directly phosphorylate PR or co-activators
    (1) or promote PR phosphorylations through CK2 and CDK2 (see text for details).
    Alternatively, activation of various cytoplasmic signaling pathways may phosphorylate
    and increase transcriptional activity of other transcription factors, independent
    of PREs (2). Rapid extranuclear activation of ER/PR complexes by progestins activates
    MAPK leading to a formation of phospho-PR/MAPK/Msk1 (Mitogen and stress-activated
    protein kinase 1), chromatin remodeling and enhanced MMTV and PRE-containing gene
    transcription (3). PR extranuclear activation of Src/PI3K/Akt may stimulate focal
    adhesion kinase (FAK) or ribosomal S6 kinase 1 (RSK1) triggering actin cytoskeleton
    remodeling and promotion of cell motility (4). Alternatively, PR extranuclear
    signaling may cross-communicate with growth factor signaling such as epidermal
    growth factor (EGF) leading to activation of MAPK and downstream events (5). Membrane
    localized progestin receptor (mPR) unrelated to the classical PR mediates progestin
    extranuclear signaling through GPCR-like membrane proteins via modulation of adenylate
    cyclase (AC), cyclic adenosine monophosphate (cAMP) and protein kinase A (PKA).
    mPR has been reported to activate MAPK and PI3K/Akt signaling pathways. More work
    is needed to define the physiological significance of extranuclear mPR activation
    of these several cytoplasmic signaling pathways in BC cells.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK10
  - MAPK14
  - PIK3R5
  - MAPK13
  - PIK3CA
  - MAPK12
  - PIK3R4
  - S100A6
  - PIK3CB
  - ARAF
  - TYK2
  - MAPK11
  - PSPC1
  - STAT6
  - TF
  - MAPK1
  - MAPK9
  - MAPK3
  - AKT2
  - VSX1
  - JAK1
  - JAK2
  - JAK3
  - PIK3R6
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY5
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - AKT3
  - ADCY10
  - PRKACG
  - PRKACA
  - PRKACB
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - RAF1
  - BRAF
  - CDK2
  - ADCY6
  - EGFR
  - PTK2
  - GRB2
  - HBD
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT5A
  - STAT5B
  - PRKAR2B
  - MAPK8
  - CSNK2B
  - ADCY7
  - ADCY8
  - AKT1
  - MAP2K2
  - MAP2K1
  - RPS6KA5
  - CSNK2A1
  - ADCY9
  - ADCY4
  - CSNK2A2
  - SP1
  - RPS6KA1
  - DUSP6
  - SRC
  - SOS2
  - EGF
  - SOS1
  - PPD
  - PG PG
  - Cancer
  - Noonan syndrome
genes:
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PRA
  symbol: PRA
  source: hgnc_alias_symbol
  hgnc_symbol: S100A6
  entrez: '6277'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: PSP1
  symbol: PSP1
  source: hgnc_alias_symbol
  hgnc_symbol: PSPC1
  entrez: '55269'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: TF
  symbol: TF
  source: hgnc_symbol
  hgnc_symbol: TF
  entrez: '7018'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PPD
  symbol: PPD
  source: hgnc_alias_symbol
  hgnc_symbol: VSX1
  entrez: '30813'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY1
  entrez: '107'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY2
  entrez: '108'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY3
  entrez: '109'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY5
  entrez: '111'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY10
  entrez: '55811'
- word: CAMP&PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: CAMP&PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: CAMP&PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: CAMP&PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: CAMP&PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: CAMP&PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: CDK2
  symbol: CDK2
  source: hgnc_symbol
  hgnc_symbol: CDK2
  entrez: '1017'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY6
  entrez: '112'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: FAK
  symbol: FAK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
- word: Grb2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: HBD
  symbol: HBD
  source: hgnc_symbol
  hgnc_symbol: HBD
  entrez: '3045'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: CAMP&PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: CK2
  symbol: CK2
  source: bioentities_symbol
  hgnc_symbol: CSNK2B
  entrez: '1460'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY7
  entrez: '113'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY8
  entrez: '114'
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MSK1
  symbol: MSK1
  source: hgnc_alias_symbol
  hgnc_symbol: RPS6KA5
  entrez: '9252'
- word: CK2
  symbol: CK2
  source: bioentities_symbol
  hgnc_symbol: CSNK2A1
  entrez: '1457'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY9
  entrez: '115'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY4
  entrez: '196883'
- word: CK2
  symbol: CK2
  source: bioentities_symbol
  hgnc_symbol: CSNK2A2
  entrez: '1459'
- word: SP1
  symbol: SP1
  source: hgnc_symbol
  hgnc_symbol: SP1
  entrez: '6667'
- word: RSK1
  symbol: RSK1
  source: hgnc_alias_symbol
  hgnc_symbol: RPS6KA1
  entrez: '6195'
- word: DUSP6
  symbol: DUSP6
  source: hgnc_symbol
  hgnc_symbol: DUSP6
  entrez: '1848'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
chemicals:
- word: PPD
  source: MESH
  identifier: D014373
- word: PG PG
  source: MESH
  identifier: D010400
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
